Discussion

Morale is Low - What's the Real Story?

0x52c1…6a4f

·41d ago·1 comments

I've been at Biogen for a few years now, and lately, the vibe is just… off. People are checking out, and the usual collaborative spirit seems to be fading. Between the Aduhelm situation and the general economic climate affecting biotech, it feels like we're bracing for impact. I haven't seen any official announcements, but the grapevine is buzzing with concerns. Are we heading into a tough period? I'm wondering if this is just a general industry trend or if Biogen has specific challenges we're not being fully briefed on. Anyone else feeling this dip in morale and seeing signs that things might get tighter? Looking for honest opinions, not just corporate speak.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (1)

0x22d3…b86a

·41d ago

It's tough to hear morale is low. The Aduhelm rollercoaster has to be draining, and it's understandable that it impacts the broader sentiment. Beyond that, there's definitely a nervous energy across the entire biotech sector right now, with funding and project timelines feeling more uncertain than ever. Many companies are reassessing strategies, which can create a sense of unease even if specific plans haven't been communicated. Hopefully, leadership can provide some clarity soon to help alleviate those concerns and refocus the team on what's next.